These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21394775)

  • 21. In vivo (1)H MRSI of glycine in brain tumors at 3T.
    Ganji SK; Maher EA; Choi C
    Magn Reson Med; 2016 Jan; 75(1):52-62. PubMed ID: 25651788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain.
    Kaminogo M; Ishimaru H; Morikawa M; Ochi M; Ushijima R; Tani M; Matsuo Y; Kawakubo J; Shibata S
    Neuroradiology; 2001 May; 43(5):353-63. PubMed ID: 11396738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactate as clinical tumour biomarker: Optimization of lactate detection and quantification in MR spectroscopic imaging of glioblastomas.
    Bisdas S; Schäfer R; Kolb R; Bender B; Klose U
    Eur J Radiol; 2020 Sep; 130():109171. PubMed ID: 32668356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localized in vivo human 1H MRS at very short echo times.
    Zhong K; Ernst T
    Magn Reson Med; 2004 Oct; 52(4):898-901. PubMed ID: 15389966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of glycine distributions in gliomas.
    Maudsley AA; Gupta RK; Stoyanova R; Parra NA; Roy B; Sheriff S; Hussain N; Behari S
    AJNR Am J Neuroradiol; 2014 Jun; 35(6 Suppl):S31-6. PubMed ID: 24481330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
    Tong ZY; Toshiaki Y; Wang YJ
    Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma.
    Ramadan S; Andronesi OC; Stanwell P; Lin AP; Sorensen AG; Mountford CE
    Radiology; 2011 May; 259(2):540-9. PubMed ID: 21357517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observation of coupled 1H metabolite resonances at long TE.
    Soher BJ; Pattany PM; Matson GB; Maudsley AA
    Magn Reson Med; 2005 Jun; 53(6):1283-7. PubMed ID: 15906305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity-encoded (SENSE) proton echo-planar spectroscopic imaging (PEPSI) in the human brain.
    Lin FH; Tsai SY; Otazo R; Caprihan A; Wald LL; Belliveau JW; Posse S
    Magn Reson Med; 2007 Feb; 57(2):249-57. PubMed ID: 17260356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of glutamate in the human brain at 3 T using optimized constant time point resolved spectroscopy.
    Mayer D; Spielman DM
    Magn Reson Med; 2005 Aug; 54(2):439-42. PubMed ID: 16032664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton MRS in neurological disorders.
    Bonavita S; Di Salle F; Tedeschi G
    Eur J Radiol; 1999 May; 30(2):125-31. PubMed ID: 10401593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo detection of citrate in brain tumors by 1H magnetic resonance spectroscopy at 3T.
    Choi C; Ganji SK; Madan A; Hulsey KM; An Z; Zhang S; Pinho MC; DeBerardinis RJ; Bachoo RM; Maher EA
    Magn Reson Med; 2014 Aug; 72(2):316-23. PubMed ID: 24123337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved resolution of glutamate, glutamine and γ-aminobutyric acid with optimized point-resolved spectroscopy sequence timings for their simultaneous quantification at 9.4 T.
    Dobberthien BJ; Tessier AG; Yahya A
    NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29105187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid and macromolecules quantitation in differentiating glioblastoma from solitary metastasis: a short-echo time single-voxel magnetic resonance spectroscopy study at 3 T.
    Crisi G; Orsingher L; Filice S
    J Comput Assist Tomogr; 2013; 37(2):265-71. PubMed ID: 23493217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study.
    Kinoshita Y; Kajiwara H; Yokota A; Koga Y
    Neurosurgery; 1994 Oct; 35(4):606-13; discussion 613-4. PubMed ID: 7808603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated imaging of [
    Ratai EM; Alshikho MJ; Zürcher NR; Loggia ML; Cebulla CL; Cernasov P; Reynolds B; Fish J; Seth R; Babu S; Paganoni S; Hooker JM; Atassi N
    Neuroimage Clin; 2018; 20():357-364. PubMed ID: 30112276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
    Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
    NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo Metabolic Profiles as Determined by
    Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U
    Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T2 measurement of J-coupled metabolites in the human brain at 3T.
    Ganji SK; Banerjee A; Patel AM; Zhao YD; Dimitrov IE; Browning JD; Brown ES; Maher EA; Choi C
    NMR Biomed; 2012 Apr; 25(4):523-9. PubMed ID: 21845738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
    Wald LL; Nelson SJ; Day MR; Noworolski SE; Henry RG; Huhn SL; Chang S; Prados MD; Sneed PK; Larson DA; Wara WM; McDermott M; Dillon WP; Gutin PH; Vigneron DB
    J Neurosurg; 1997 Oct; 87(4):525-34. PubMed ID: 9322843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.